Further analysis showed that 82% of patients with isocitrate dehydrogenase (IDH)-wild-type (n = 42 patients) and 100% of patients with an IDH-mutant glioma showed corpus callosum infiltration. Here, IDH3A is linked to central nervous system cancer.